Skip to content

Curriculum & Schedule 2025

Curriculum

The virtual course will use a mix of short (20-30 min) lectures, case studies, and break-out discussion groups.

Agenda


2025 Agenda

  • Times are listed in pacific time, separate theme for each day.
  • Each talk is a 20-minute presentation, including a brief Q&A / Expert panel discussion sessions (2-4 people)
  • Breakout discussions will encourage interactions among participants

Recordings 2025

Session Recordings

Innate immunity and hostdirected therapies; Tom Hawn
Adaptive immunity to M.tuberculosis; Chetan Seshadri
Granulomas and in vivo model of TB pathogenesis: dissecting mechanisms of protection and dissemination; Kevin Urdahl
TB controlled human infection model (TB-CHIM); Rhea Coler
TB vaccine trials; Andrew Fiore-Gartland
Session 1 Panel Discussion

Pathogenesis and drug targets; David Sherman
Systems biology approaches to drug discovery; Nitin Baliga
Drug discovery and development; Arielle Butts
Treatment regimens, including PLHIV; Adrienne Shapiro
Treatment for drug-resistant and extrapulmonary; Bijan Ghassemieh
Session 2 Panel Discussion

TB biomarkers and diagnostics; Paul Drain
Novel biomarkers for incipient/subclinical TB; Javeed Shah
Tongue swabs and other nonsputum based diagnostics; Jerry Cangelosi
Organizing, Funding, and Media for TB advocacy; Erin McConnell, TAG
Session 3 Panel Discussion

Aerosol biology and TB transmission; David Horne
Resister populations and Mtb transmission; Jason Simmons
Imaging and other clinical measures for risk of Mtb transmission; Engi Attia
TB preventive treatment and novel regimens; Jennifer Ross
TB in Pregnancy; Sylvia LaCourse
Session 4 Panel Discussion

TB modeling and phylogenetics; Josh Herbeck
Using mobile health technologies for TB; Sarah Iribarren
Pediatrics and special populations; Rafael Hernandez
Diagnostics for pregnant women and PLHIV; Grace John-Stewart

YouTube playlist

Speakers


Speaker Bios


Curriculum Committee